BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 18799702)

  • 1. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.
    Saunier M; Monnier-Benoit S; Mauny F; Dalstein V; Briolat J; Riethmuller D; Kantelip B; Schwarz E; Mougin C; Prétet JL
    J Clin Microbiol; 2008 Nov; 46(11):3678-85. PubMed ID: 18799702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
    Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
    Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
    Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer.
    Wu Z; Yu L; Lei X; Qin Y; Zhang X; Chen W; Qiao Y
    J Clin Virol; 2018 Nov; 108():6-11. PubMed ID: 30196013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16.
    Hong D; Liu J; Hu Y; Lu X; Li B; Li Y; Hu D; Lu W; Xie X; Cheng X
    BMC Cancer; 2017 Feb; 17(1):136. PubMed ID: 28202002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
    Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
    Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
    Zheng Y; Peng ZL; Lou JY; Wang H
    Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical evaluation of HPV16 gene copy number quantification by SYBR green PCR.
    Roberts I; Ng G; Foster N; Stanley M; Herdman MT; Pett MR; Teschendorff A; Coleman N
    BMC Biotechnol; 2008 Jul; 8():57. PubMed ID: 18652663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
    Wang JT; Ding L; Gao ES; Cheng YY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions.
    Yoshida T; Sano T; Kanuma T; Owada N; Sakurai S; Fukuda T; Nakajima T
    Int J Gynecol Cancer; 2008; 18(1):121-7. PubMed ID: 17506843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
    Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
    Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of HPV 16 viral load and the E2/E6 ratio for the prediction of cervical cancer risk among Chinese women.
    Chang L; He X; Yu G; Wu Y
    J Med Virol; 2013 Apr; 85(4):646-54. PubMed ID: 23364617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of human papillomavirus 16 physical status through E1/E6 and E2/E6 ratio analysis.
    Tsakogiannis D; Kyriakopoulou Z; Ruether IGA; Amoutzias GD; Dimitriou TG; Diamantidou V; Kotsovassilis C; Markoulatos P
    J Med Microbiol; 2014 Dec; 63(Pt 12):1716-1723. PubMed ID: 25212758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology.
    Kulmala SM; Syrjänen SM; Gyllensten UB; Shabalova IP; Petrovichev N; Tosi P; Syrjänen KJ; Johansson BC
    J Clin Pathol; 2006 May; 59(5):513-7. PubMed ID: 16484445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.
    Li W; Wang W; Si M; Han L; Gao Q; Luo A; Li Y; Lu Y; Wang S; Ma D
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1355-61. PubMed ID: 18478264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV16 E6 polymorphism and physical state of viral genome in relation to the risk of cervical cancer in women from the south of Poland.
    Szostek S; Zawilinska B; Klimek M; Kosz-Vnenchak M
    Acta Biochim Pol; 2017; 64(1):143-149. PubMed ID: 27801430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
    Cheung JL; Cheung TH; Yu MY; Chan PK
    Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma.
    Wu MZ; Li WN; Cha N; Tian LX; Zhang YI; Wu X; Guo KJ; Wu GP
    Cell Transplant; 2018 Sep; 27(9):1401-1406. PubMed ID: 30056761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma.
    Choi YJ; Lee A; Kim TJ; Jin HT; Seo YB; Park JS; Lee SJ
    J Gynecol Oncol; 2018 May; 29(3):e38. PubMed ID: 29400024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiation of an integrated and episomal HPV-16 DNA using real-time PCR in cervical specimens of women diagnosed with intraepithelial lesions and invasive cervical cancer].
    Szostek S; Zawilińska B; Klimek M; Wójcik K; Koprynia M; Kosz-Vnenchak M
    Ginekol Pol; 2011 Jun; 82(6):441-5. PubMed ID: 21853934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.